Tyra Biosciences (TYRA) Assets Average (2021 - 2026)

Quarterly Assets Average fell 1.75% to $347.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $347.3 million through Mar 2026, down 1.75% year-over-year, with the annual reading at $323.1 million for FY2025, 9.63% up from the prior year.

Tyra Biosciences filings provide 6 years of Assets Average readings, the most recent being $347.3 million for Q1 2026.

  • Assets Average hit $347.3 million in Q1 2026 for Tyra Biosciences, up from $292.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $398.6 million in Q2 2024 and bottomed at $232.1 million in Q4 2023.
  • Average Assets Average over 5 years is $308.7 million, with a median of $302.8 million recorded in 2022.
  • The largest annual shift saw Assets Average soared 60.3% in 2024 before it dropped 21.46% in 2025.
  • Tyra Biosciences' Assets Average stood at $271.1 million in 2022, then fell by 14.38% to $232.1 million in 2023, then soared by 60.3% to $372.1 million in 2024, then decreased by 21.46% to $292.2 million in 2025, then grew by 18.85% to $347.3 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Assets Average are $347.3 million (Q1 2026), $292.2 million (Q4 2025), and $311.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 13.04 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 33.42 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 331.70 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.06 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.71 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 26.03 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.05 Bn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - 347.32 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 347.32 Mn
Dec 31, 2025 292.23 Mn
Sep 30, 2025 311.68 Mn
Jun 30, 2025 332.49 Mn
Mar 31, 2025 353.52 Mn
Dec 31, 2024 372.08 Mn
Sep 30, 2024 386.53 Mn
Jun 30, 2024 398.60 Mn
Mar 31, 2024 315.30 Mn
Dec 31, 2023 232.11 Mn
Sep 30, 2023 244.19 Mn
Jun 30, 2023 252.53 Mn
Mar 31, 2023 260.62 Mn
Dec 31, 2022 271.08 Mn
Sep 30, 2022 281.55 Mn
Jun 30, 2022 293.04 Mn
Mar 31, 2022 302.84 Mn
Dec 31, 2021 311.34 Mn